lunaphore is a biotechnology company developing the next-generation spatial biology platform for immuno-oncology research and diagnostics. its full stack platform, ffex, combines microfluidics, artificial intelligence, and rapid staining technologies for enhanced precision and efficiency in analyzing tissue samples. this allows for detailed insights into tissue structures, supporting the development of better targeted treatments and aiding pathologists in making informed decisions. by automating and accelerating the diagnostic process, lunaphore aims to improve cancer research and treatment.